Steven L. Hoerter - Dec 12, 2023 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Role
President and CEO, Director
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Stock symbol
DCPH
Transactions as of
Dec 12, 2023
Transactions value $
-$471,217
Form type
4
Date filed
12/14/2023, 04:05 PM
Previous filing
Oct 31, 2023
Next filing
Feb 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Award +62.5K +152.71% 103K Dec 12, 2023 Direct F1
transaction DCPH Common Stock Sale -$471K -30.7K -29.65% $15.37 72.8K Dec 13, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 15, 2023, the Reporting Person was granted restricted stock units ("RSUs"), which vest upon the satisfaction of three performance criteria. On December 12, 2023, the Issuer's Compensation Committee confirmed that performance criteria one had been met, resulting in the vesting of 62,500 RSUs.
F2 This sale was to cover tax liabilities in the vesting of RSUs.